Dear colleagues,
On behalf of the European Academy of Neurology and the European Alzheimer’s disease consortium (EADC), we would like to invite all members to express their opinion regarding the use of Mild Cognitive Impairment (MCI) in current European practice through an online survey.
The survey regards the usefulness of Mild Cognitive Impairment (MCI) as a clinical entity and the usefulness of recent criteria for Alzheimer’s disease (AD) in subjects with MCI (Prodromal AD or MCI due to AD). Clarifying the use of MCI in clinical practice will be profitable for coordination, better understanding and facilitation of the practices within scientific as well as clinical settings.
The European survey is an extended version of a survey that was done among members of the American Academy of Neurology, which was published in Neurology
(J.S. Roberts, J.H. Karlawish, W.R. Uhlmann, et al. Neurology 2010;75;425 DOI 10.1212/WNL.0b013e3181eb5872).
The survey will take 20 minutes and can be accessed by following this link:
https://www.survey.bris.ac.uk/coe/mci
To get representative results we would like to ask all members to fill out the survey before December 8th 2014.
Kind regards,
Daniela Bertens
(PhD student at the Alzheimer Center, VU medical center Amsterdam)
On behalf of:
Dr P.J. Visser
Prof Ph Scheltens
Prof Reinhold Schmidt, Chair of the Subspecialty Scientific Panel on Dementia
